Adverum Biotech

124 people · 5 jobs
‌

Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet ag... Read more

Industries

Employees

51-200

Links


Org chart

Laurent Fischer
President & CEO
Collapse
R. Andrew Ramelmeier
Chief Technology Officer
Romuald Corbau
Chief Scientific Officer
John Rakow
Senior Legal Advisor
Dena House
SVP, Human Resources, Organizational Development & Learning
Bill Tan
SVP & Head, Global Clinical Operations
Aneta Ferguson
Svp, General Counsel
Andy Ramelmeier
Chief Technology Officer
Peter Soparkar
Chief Operating Officer

Board & advisors